The Restoration of the Vaginal Microbiota After Treatment for Bacterial Vaginosis with Metronidazole or Probiotics

[1]  A. Stapleton,et al.  Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  K. Nelson,et al.  Diversity of Cervicovaginal Microbiota Associated with Female Lower Genital Tract Infections , 2011, Microbial Ecology.

[3]  K. Workowski,et al.  Sexually transmitted diseases treatment guidelines, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[4]  Fang Liu,et al.  Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis , 2010, BMC Genomics.

[5]  Gregory B. Gloor,et al.  Deep Sequencing of the Vaginal Microbiota of Women with HIV , 2010, PloS one.

[6]  Chaochun Wei,et al.  Analysis of Oral Microbiota in Children with Dental Caries by PCR-DGGE and Barcoded Pyrosequencing , 2010, Microbial Ecology.

[7]  P. Gajer,et al.  Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.

[8]  L. Meyn,et al.  Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous Lactobacilli. , 2009, The Journal of infectious diseases.

[9]  G. Reid,et al.  Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. , 2009, Canadian journal of microbiology.

[10]  J. Marrazzo,et al.  Changes in Vaginal Bacterial Concentrations with Intravaginal Metronidazole Therapy for Bacterial Vaginosis as Assessed by Quantitative PCR , 2009, Journal of Clinical Microbiology.

[11]  L. Petricevic,et al.  The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis , 2008, BJOG : an international journal of obstetrics and gynaecology.

[12]  H. Kumon,et al.  A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. , 2006, International journal of antimicrobial agents.

[13]  S. Garland,et al.  High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. , 2006, The Journal of infectious diseases.

[14]  G. Reid,et al.  Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. , 2006, Microbes and infection.

[15]  P. Nyirjesy,et al.  Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. , 2006, American journal of obstetrics and gynecology.

[16]  J. Marrazzo,et al.  Molecular identification of bacteria associated with bacterial vaginosis. , 2005, The New England journal of medicine.

[17]  J. Fortenberry,et al.  Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis , 2004, BMC infectious diseases.

[18]  Gale R. Burstein,et al.  Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.

[19]  S. Shott,et al.  Defense factors of vaginal lactobacilli. , 2001, American journal of obstetrics and gynecology.

[20]  A. Bruce,et al.  Oral probiotics can resolve urogenital infections. , 2001, FEMS immunology and medical microbiology.

[21]  Ichael,et al.  METRONIDAZOLE TO PREVENT PRETERM DELIVERY IN PREGNANT WOMEN WITH ASYMPTOMATIC BACTERIAL VAGINOSIS , 2000 .

[22]  K. Holmes,et al.  Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. , 1996, The Journal of infectious diseases.

[23]  M A Krohn,et al.  The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  J. Sobel,et al.  Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin. , 1993, The Journal of infectious diseases.

[25]  M A Krohn,et al.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation , 1991, Journal of clinical microbiology.

[26]  R. Knight,et al.  Microbiota restoration: natural and supplemented recovery of human microbial communities , 2011, Nature Reviews Microbiology.

[27]  L. Mosca,et al.  Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[28]  J. Carey,et al.  Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis , 2001 .

[29]  K. Holmes,et al.  Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations , 1983 .

[30]  King K. Holmes,et al.  Diagnostic Criteria and Microbial and Epidemiologic Associations , 1983 .